Enzyme-Linked Immunosorbent Assay Method for Detection of Cytomegalovirus Strain-Specific Antibody Responses
- 1 February 2009
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 16 (2), 288-290
- https://doi.org/10.1128/cvi.00281-08
Abstract
Reliable methods for the detection of cytomegalovirus (CMV) strain-specific serological responses are lacking. We describe a simple and reliable enzyme-linked immunosorbent assay method developed to detect antibodies against the polymorphic epitopes within the two envelope glycoproteins of CMV, glycoproteins H and B. This assay is useful for the detection of serologic responses to CMV strains and the identification of CMV reinfections.Keywords
This publication has 16 references indexed in Scilit:
- CONGENITAL CYTOMEGALOVIRUS INFECTION IN A HIGHLY SEROPOSITIVE SEMI-URBAN POPULATION IN INDIAThe Pediatric Infectious Disease Journal, 2008
- Cytomegalovirus Strain Diversity in Seropositive WomenJournal of Clinical Microbiology, 2008
- Association of the Outcome of Renal Transplantation with Antibody Response to Cytomegalovirus Strain--Specific Glycoprotein H EpitopesClinical Infectious Diseases, 2007
- Risk Factors for and Clinical Outcome of Congenital Cytomegalovirus Infection in a Peri-Urban West-African Birth CohortPLOS ONE, 2007
- Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?Journal of Clinical Virology, 2006
- Association between Genital Tract Cytomegalovirus Infection and Bacterial VaginosisThe Journal of Infectious Diseases, 2005
- Genetic polymorphisms among human cytomegalovirus (HCMV) wild‐type strainsReviews in Medical Virology, 2004
- Mixed Cytomegalovirus Glycoprotein B Genotypes in Immunocompromised PatientsClinical Infectious Diseases, 2004
- Cytomegalovirus gB Genotype Distribution Differs in Human Immunodeficiency Virus--Infected Patients and Immunocompromised Allograft RecipientsThe Journal of Infectious Diseases, 1997
- An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirusJournal of Medical Virology, 1993